Evidence map›Paper›PMID 25632347›Full record

ArticleOrganic chemistry frontiers : an international journal of organic chemistry2014

Function through bio-inspired, synthesis-informed design: step-economical syntheses of designed kinase inhibitors†Dedicated to Max Malacria, a friend and scholar whose science and creative contributions to step-economical synthesis have inspired us all and moved the field closer to the ideal.‡Electronic supplementary information (ESI) available: Synthetic procedures and spectral data. See DOI: 10.1039/c4qo00228hClick here for additional data file.

Paul A Wender, Alison D Axtman, Jennifer E Golden, Jung-Min Kee, Lauren E Sirois, Ryan V Quiroz, Matthew C Stevens

Open access · hybridAbstract read
In one paragraph

Article in Organic chemistry frontiers : an international journal of organic chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Staurosporine as an Antifungal Agent.International journal of molecular sciences · 2025
    Review
  2. Review
  3. Article
  4. Function through synthesis-informed design.Accounts of chemical research · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Paul A WenderDepartment of Chemistry and Department of Chemical and Systems Biology , Stanford University , Stanford , CA 94305 , USA . Email: wenderp@stanford.edu.
Alison D AxtmanDepartment of Chemistry and Department of Chemical and Systems Biology , Stanford University , Stanford , CA 94305 , USA . Email: wenderp@stanford.edu.
Jennifer E GoldenDepartment of Chemistry and Department of Chemical and Systems Biology , Stanford University , Stanford , CA 94305 , USA . Email: wenderp@stanford.edu.
Jung-Min KeeDepartment of Chemistry and Department of Chemical and Systems Biology , Stanford University , Stanford , CA 94305 , USA . Email: wenderp@stanford.edu.
Lauren E SiroisDepartment of Chemistry and Department of Chemical and Systems Biology , Stanford University , Stanford , CA 94305 , USA . Email: wenderp@stanford.edu.
Ryan V QuirozDepartment of Chemistry and Department of Chemical and Systems Biology , Stanford University , Stanford , CA 94305 , USA . Email: wenderp@stanford.edu.
Matthew C StevensDepartment of Chemistry and Department of Chemical and Systems Biology , Stanford University , Stanford , CA 94305 , USA . Email: wenderp@stanford.edu.
Center for Systems Biology · US

Funding

SYNTHETIC STUDIES RELATED TO CANCER RESEARCH/TREATMENTR01CA031845 · NCI · STANFORD UNIVERSITY · PI PAUL Anthony WENDER · 1985 to 2026
$6.9M
Synthetic Studies Related to Cancer Research/TreatmentR37CA031845 · NCI · STANFORD UNIVERSITY · PI WENDER, PAUL ANTHONY · 2006 to 2015
$4.5M
NCI NIH HHS R01 CA031845NCI NIH HHS R37 CA031845
6 · The paper itself

Abstract

The human kinome comprises over 500 protein kinases. When mutated or over-expressed, many play critical roles in abnormal cellular functions associated with cancer, cardiovascular disease and neurological disorders. Here we report a step-economical approach to designed kinase inhibitors inspired by the potent, but non-selective, natural product staurosporine, and synthetically enabled by a novel, complexity-increasing, serialized [5 + 2]/[4 + 2] cycloaddition strategy. This function-oriented synthesis approach rapidly affords tunable scaffolds, and produced a low nanomolar inhibitor of protein kinase C.

Identifiers

PMID25632347
PMCPMC4304288
OpenAlexW2169416079

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.